@article{TCR10742,
author = {Anna Joy and Burt Gary Feuerstein},
title = {AKT inhibition: a bad AKT inhibitor in liver injury and tumor development?},
journal = {Translational Cancer Research},
volume = {5},
number = {Suppl 6},
year = {2016},
keywords = {},
abstract = {Cells respond to growth signals by activating internal programs that coordinate growth, division and death. One of these, the PI3K/AKT pathway, is frequently activated in human cancer (1). The serine/threonine kinase AKT is a key actor that regulates development, metabolism and the immune response (2,3).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/10742}
}